Stay updated on Surufatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib in Advanced Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a consolidated Locations section listing California, Colorado, Florida, New York, Tennessee, Texas, and Virginia. Replaced the previous per-state location subsections with the consolidated Locations section and updated Revision: v3.3.3.SummaryDifference0.7%

- Check41 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed and may not be about the study, and the Revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check48 days agoChange DetectedThe site-wide notice about government funding operating status was removed from the page, so the alert is no longer displayed on the study details screen.SummaryDifference0.3%

- Check63 days agoChange DetectedMinor formatting and layout adjustments observed between the two screenshots; there are no changes to core trial information such as the title, eligibility criteria, locations, or primary endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check91 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

- Check98 days agoChange DetectedThe page now declares Revision: v3.1.0 instead of v3.0.2, indicating a new release/version update.SummaryDifference0.1%

Stay in the know with updates to Surufatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib in Advanced Solid Tumors Clinical Trial page.